The main reason for development of CF for the Chuvash − the fifth in population number (1.5 mln) nationality in Russia is of the "mild" p.E92K mutation (p.Glu92Lys, c.274G>A). Objective: To identify the clinical and functional characteristics of the course of CF in the patients-carriers of p.E92K mutation. Materials and Methods: Group 1: 26 adult CF patients homozygous or heterozygous for E92K, group 2: 103 adult patients homozygous for F508del. Age, age diagnosis, BMI, level of chloride in sweat, spirometry parameters, frequency of some complications [CF related diabetes (CFRD), liver cirrhosis with portal hypertension (LCPH), distal intestinal obstruction syndrome (DIOS)/meconium ileus (MI) in past medical history, cholelithiasis, urolithiasis, pulmonary hypertension (PH), asthma] were estimated. Results are described as mean±SD/median (IQR). Results: The median age group 1 was: 26.0 (5.95) years, higher than in the group 2 − 23.6 (6.5) years (p = 0.007); age diagnosis of patients with E92K was: 13.3 (9.2), higher than among homozygous for F508del − 1.9 (4.5) years (p < 0.001). There was no significant difference in the level of chloride in sweat (101±30.5 mmol/l vs 103±32 mmol/l respectively) in the two groups. The spirometry parameters, BMI, the frequency of LCPH, DIOS/MI, cholelithiasis, urolithiasis, asthma and PH had not significant difference. CFRD had frequency in the group of the patients homozygous for F508del, and CFRD in group p.E92K was never once identified (p = 0.046). Conclusion: p.E92K mutation in patients-carriers is associated with late onset age, significant low frequency of CERD, what is likely connected with the "mildness" of this mutation.
"Interdepartmental and interdisciplinary working group on rare diseases" runs under the Czech Ministry of Health, and coordinates the establishment of centres for rare diseases. A team of experts from CF Centre in University Hospital Brno currently cares for 64 children and 34 adults with Cystic Fibrosis (CF). University Hospital Brno is also responsible for newborn screening for CF(NSCF) for the Moravia region. From December 2009 till the end of December 2013, 161 917 newborns were examined under the NSCF at the University Hospital Brno. DNA analysis of the CFTR gene was carried out in 1846 newborns, representing 1.14%. One or two mutations in CFTR gene were found in 10% of newborns. We detected 20 different mutations in the CFTR gene, the most frequent were the mutations F508del (113), CFTRdele2,3 (21 kb) (18) and D1152H (14) . The DNA analysis of the CFTR gene we also perform within the genetic prevention for 400-500 people per year, which represent about 20% of patients examined in our laboratory of DNA diagnostics. In this group, we detected the pathological CF allele in more than 15% individuals. Centres for Orphan cooperate with patient organisations associated in the Czech Association of Rare Diseases. An important part of the work of all experts on rare diseases is an effort to raise awareness about rare diseases among specialists and the public. Lecture devoted to Cystic Fibrosis in November 2013 was a part of the activities within the European day for CF. Teaching of Clinical Genetics at Masaryk University Brno and public lectures dedicated on rare diseases in the Mendel Museum Masaryk University (www.mendelmuseum.muni.cz) illustrate activities our CF Center.
